Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biolase (BIOL)
OTHER OTC:BIOL
Holding BIOL?
Track your performance easily
BIOL Stock Chart & Stats
Day’s Range$0.02 - $0.06
52-Week Range― - ―
Previous Close$0.06
Volume4.60M
Average Volume (3M)N/A
Market Cap
$548.96K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 06, 2024EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,597,056
10 Day Avg. Volume562,108
30 Day Avg. Volume249,138
Standard Deviation0.33
R-Squared0.01
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)-0.16
Price to Sales (P/S)0.01
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biolase News
PremiumCompany Announcements
Biolase Announces Common Stock Shares UpdateOwnership Overview
0.60%
Insiders
0.02%
Mutual Funds
0.44% Other Institutional Investors
98.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIOL FAQ
What was Biolase’s price range in the past 12 months?
Currently, no data Available
What is Biolase’s market cap?
Currently, no data Available
When is Biolase’s upcoming earnings report date?
Biolase’s upcoming earnings report date is Nov 06, 2024 which is 21 days ago.
How were Biolase’s earnings last quarter?
Biolase released its earnings results on Aug 08, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.075 by -$0.005.
Is Biolase overvalued?
According to Wall Street analysts Biolase’s price is currently Overvalued.
Does Biolase pay dividends?
Biolase does not currently pay dividends.
What is Biolase’s EPS estimate?
Biolase’s EPS estimate is -$0.08.
How many shares outstanding does Biolase have?
Currently, no data Available
What happened to Biolase’s price movement after its last earnings report?
Biolase reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.075. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Biolase?
Currently, no hedge funds are holding shares in BIOL
---
Biolase Stock Smart Score
Company Description
Biolase
BIOLASE, Inc. is a medical device company, which engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.
---
BIOL Earnings Call
Q1 2024
0:00 / 0:00
---
BIOL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BIOL
1 Year
1 Year Success Rate
1/11 ratings generated profit
1 Year Average Return
-71.57%
reiterated a buy rating 6 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -71.57% per trade.
---